Prevention of stroke in patients with atrial fibrillation and cancer is challenging as patients are at increased bleeding and thrombotic risk. Left atrial appendage occlusion (LAAO) has evolved as a promising device strategy for stroke prevention to reduce both bleeding stroke risk, though no data exists on its efficacy in patients with cancer.

Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and Cancer

The Foundation in Cardiology Practice program will offer a comprehensive review of the fundamentals and most important changes in cardiovascular medicine. Program topics will provide details to ensure patients receive the highest, most up-to-date quality of care and achieve the best possible outcomes when returning to your practice.   Electronic posters offer a great opportunity to connect with a look into the future and learn from colleagues to keep the best interest of the patient in mind when providing care.